ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 138 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q4 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $35,617 | -10.9% | 1,394 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $39,980 | +19.7% | 1,394 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $33,414 | +41.3% | 1,394 | 0.0% | 0.00% | +100.0% |
| Q4 2022 | $23,642 | +14.4% | 1,394 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $20,659 | -5.8% | 1,394 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $21,942 | -41.6% | 1,394 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $37,582 | -83.9% | 1,394 | -77.9% | 0.00% | -66.7% |
| Q4 2021 | $233,496 | -22.5% | 6,309 | 0.0% | 0.00% | -25.0% |
| Q3 2021 | $301,444 | +42.6% | 6,309 | +1.0% | 0.00% | +33.3% |
| Q2 2021 | $211,398 | -18.1% | 6,247 | 0.0% | 0.00% | -25.0% |
| Q1 2021 | $258,001 | -4.8% | 6,247 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $270,995 | +33.5% | 6,247 | +32.1% | 0.00% | 0.0% |
| Q3 2020 | $202,917 | +4.0% | 4,730 | +13.3% | 0.00% | +33.3% |
| Q2 2020 | $195,093 | – | 4,174 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 208,886 | $5,337,037 | 1.71% |
| Portolan Capital Management | 276,505 | $7,064,703 | 0.66% |
| Nikko Asset Management Americas, Inc. | 1,388,574 | $35,422,523 | 0.42% |
| Green Alpha Advisors, LLC | 21,538 | $550,296 | 0.42% |
| SummerHaven Investment Management, LLC | 22,326 | $570,429 | 0.42% |
| ARK Investment Management | 1,901,546 | $48,584,508 | 0.37% |
| Granahan Investment Management | 398,862 | $10,190,924 | 0.36% |
| FEDERATED HERMES, INC. | 4,711,512 | $120,379,132 | 0.32% |
| Woodline Partners LP | 1,069,814 | $27,333,748 | 0.32% |
| Diametric Capital, LP | 26,130 | $667,621 | 0.28% |